What Really Mattered With Inovio's Q3 Update

Inovio Pharmaceuticals (NASDAQ: INO) stock isn't anywhere near its lofty levels set this summer. However, investors probably won't complain about a year-to-date gain of close to 170%.  

The biotech had an opportunity for a catalyst when it announced third-quarter results after the market closed on Monday. Here are the highlights from Inovio's Q3 update.

Image Source: Getty Images.

Continue reading

Source Fool.com